LMAN1, MCFD2 mutation screen for Combined FV & FIII deficiency

Description: 
Analysis of the LMAN1 and MCFD2 genes by PCR amplification and sequencing of the coding region and splice junctions is the gold standard approach.
Clinical details: 
Combined deficiency of FV and FVIII is due to mutations in either LMAN1 or MCDF2, genes which code for proteins which form a complex required for the export of FV and FVIII from the endoplasmic reticulum. A defect in this transport mechanism leads to mild deficiencies of both FVIII and FV - levels are usually between 5-30%. This autosomal recessive disorder, with a frequency estimated at 1:100,000 to 1:1,000,000, generally presents as mucosal bleeding and menorrhagia in females, with exessive trauma related bleeding. This rare disorder, although found world-wide, is more common in the Mediterranean basin, the result of founder effect and consanguinity.
Thus far mutations have more commonly been identified in LMAN1, although this may be biased by the fact that it was identified before MCFD2.
Reference range: 

n/a

Synonyms or keywords: 
Combined FV & FVIII deficiency. LMAN1 MCFD2 Hereditary bleeding disorder.
Units: 
n/a
Sample type and Volume required: 
1 x Edta
Call in advance: 
no
Turnaround time: 
12 weeks
Storage and transport: 
transport at ambient temperature
Contacts:
Molecular Haemostasis Laboratory at St Thomas'
020 7188 2798
Haemostasis and Thrombosis
North Wing - 4th floor
St Thomas' Hospital
Westminster Bridge Road
London SE1 7EH

Laboratory opening times
Monday - Friday 09.00 - 17.00
For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 14/03/2017